Safety and immunogenicity of 2 formulations of an intramuscular A/H5N1 pandemic influenza vaccine in children.
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors sanofi pasteur
- 15 Apr 2011 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov.
- 23 Feb 2010 Planned end date changed from 1 Mar 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 23 Feb 2010 Actual patient number (240) added as reported by ClinicalTrials.gov.